<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="36660">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01692821</url>
  </required_header>
  <id_info>
    <org_study_id>OPHT-180312</org_study_id>
    <nct_id>NCT01692821</nct_id>
  </id_info>
  <brief_title>Effect of Systemic Hypoxia and Hyperoxia on Retinal Oxygen Saturation</brief_title>
  <official_title>Effect of Systemic Hypoxia and Hyperoxia on Retinal Oxygen Saturation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <authority>Austria: Agency for Health and Food Safety</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adequate perfusion and oxygenation is essential for the function of the inner retina.
      Although it is known that oxygen tension is very well autoregulated in the retina, the
      physiological mechanisms behind this regulation process are not fully explored. The
      development of new instruments for the non-invasive measurement of oxygen tension in retinal
      vessels now allows for the more precise investigation of these physiological processes. The
      current study seeks to evaluate the retinal oxygen saturation in healthy subjects while
      breathing different oxygen mixtures to achieve a hypoxic and a hyperoxic state.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Retinal oxygen saturation</measure>
    <time_frame>On the study day -  during each breathing period (6 times)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Retinal blood flow</measure>
    <time_frame>On the study day -  during each breathing period (6 times)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Retinal Oxygenation</condition>
  <condition>Retinal Blood Flow</condition>
  <arm_group>
    <arm_group_label>100% oxygen breathing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>15% oxygen in N2 breathing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>12% oxygen in N2 breathing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>100% oxygen breathing</intervention_name>
    <description>100% oxygen breathing - 30 minutes</description>
    <arm_group_label>100% oxygen breathing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>15% oxygen in N2 breathing</intervention_name>
    <description>15% oxygen in N2 breathing - 30 minutes</description>
    <arm_group_label>15% oxygen in N2 breathing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>12% oxygen in N2 breathing</intervention_name>
    <description>12% oxygen in N2 breathing - 30 minutes</description>
    <arm_group_label>12% oxygen in N2 breathing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women aged between 18 and 35 years

          -  Nonsmokers

          -  Normal findings in the medical history and physical examination unless the
             investigator considers an abnormality to be clinically irrelevant

          -  Normal laboratory values unless the investigator considers an abnormality to be
             clinically irrelevant

          -  Normal ophthalmic findings, ametropy &lt; 3 Dpt.

        Exclusion Criteria:

          -  Regular use of medication, abuse of alcoholic beverages, participation in a clinical
             trial in the 3 weeks preceding the study (except oral contraceptive)

          -  Symptoms of a clinically relevant illness in the 3 weeks before the first study day

          -  Presence of any form of anemia

          -  Blood donation during the previous 3 weeks

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerhard Garh√∂fer, Assoc. Prof. Priv.-Doz. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Pharmacology, Medical University of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Vienna, Department of Clinical Pharmacology</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 29, 2013</lastchanged_date>
  <firstreceived_date>June 14, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Gerhard Garhofer</investigator_full_name>
    <investigator_title>Assoc. Prof. Priv.-Doz. Dr.</investigator_title>
  </responsible_party>
  <keyword>retinal oxygen saturation</keyword>
  <keyword>retinal blood flow</keyword>
  <keyword>hyperoxia</keyword>
  <keyword>hypoxia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anoxia</mesh_term>
    <mesh_term>Hyperoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
